April was a big month in AI × biology. Frontier AI labs made billion-dollar moves into drug discovery. A Nobel laureate's AI designed enzymes for chemistry that nature never invented. A $500 million initiative set out to build the data foundation for virtual cells. And a general-purpose AI matched the best human scientists on a real biological design challenge.
Here are the ten biggest stories from the past four weeks - in no particular order. Each one links back to the original issue if you want more of the context.
Let’s dive in.